newsfilter
← Latest News
GlobeNewswire·

First Tracks Biotherapeutics Announces $200 Million Private Placement

SAN DIEGO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (NASDAQ:TRAX), a clinical stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in